SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

DHL and Octopharma open cold-chain logistics centre in Germany

New logistics centre in Leipzig has two temperature controlled areas

In a venture with plasma products manufacturer Octopharma, DHL has opened a €3.4m ($4.4m) cold-chain logistics centre in Germany for the pharma and life sciences industries.

Related news

News in brief

Suppliers Albemarle, Siegfried USA and Johnson Matthey join CROs, CMOs and other leaders of the services sector in New Jersey, US this week to discuss all things outsourcing.

As contract manufacturers continue to consolidate , some in the industry are questioning whether the resulting companies have the ability to offer the same services as the former individual companies. 

CRO (contract research organization) Parexel International has allowed clinical technology companies CRF Health and Clinical Ink to join its Perceptive Partner Program. 

Almac has teamed up with Welsh Academics and industrial chemistry firm Hockley International to develop enzymes capable of making drug intermediates more quickly.

Charles River Labs (CRL) has singled out China as an area of “disproportionate growth” in biologics R&D and says it is on the hunt for preclinical acquisitions in the region.

Global Industry News

Indian drugmakers to bring cheap HCV drug Sovaldi to developing world from in-PharmaTechnologist.com

Gilead has granted seven Indian drugmakers licenses to produce generic versions of its $1,000 a pill drug Sovaldi to increase access to hepatitis C medicines in 91 developing countries.

Galen plans to sell “green whistle” inhalable pain drug in UK and Ireland from in-PharmaTechnologist.com

Almac’s subsidiary Galen has licensed UK sales and marketing rights to an emergency pain drug nicknamed the “green whistle” from Australian firm Medical Developments International (MVP).

Mannkind looks to Sanofi for secondary supply of inhalable insulin API from in-PharmaTechnologist.com

Mannkind says Sanofi could become a second API supplier for its recently approved inhalable insulin drug Afrezza following its commercialisation partnership last month.

Earn Billions: Learn how at BioPharma-Reporter.com’s Biosimilars forum from BioPharma-Reporter.com

Either the folks at Hospira, Celltrion, Samsung Biologics, Teva, Merck & Co and Quintiles are hopeless romantics investing in science for its own sake or, for them, the “debate” about the potential of biosimilars has already been resolved.   

Roche: Counterfeit MabThera discovered in Germany from BioPharma-Reporter.com

A German parallel importer has informed Roche that counterfeit versions of its cancer treatment MabThera (rituximab) have been discovered in Germany.

EMA guideline on pharmacovigilance inspections comes into effect from in-PharmaTechnologist.com

As the EMA has announced that the main objectives of its pharmacovigilance legislation are largely being achieved , the agency is still implementing a number of the individual modules that make up the over-arching law.

Spotlight

Evotec confirms orphan drug development status with Shire contract

Evotec teams with Shire on Fabry's disease as pharma interest in orphans grows

Evotec has partnered with Shire to develop inhibitors against Fabry’s disease and says such collaborations will grow...

CRL nears 85% capacity use, but says sector pricing won't improve yet

CRL nears 85% capacity use, but says sector pricing won't improve yet

Charles River Laboratories is approaching its optimal capacity utilisation but says pricing will not improve until the...

CMO issues persist as Cubist announces third recall for antibiotic

CMO issues persist as Cubist announces third recall for potential glass in antibiotic

For the third time since last August, Cubist Pharmaceuticals has recalled lots of its antibiotic Cubicin injection...

AMRI: Big Pharma still reliant on CMOs for sterile injectables

Injectables outsourcing growing despite pharma M&A, says AMRI

Big Pharma is still reliant on CMOs despite talk of returning in-house, says AMRI, which has launched...

Quintiles sees strong demand from large pharma

Quintiles sees strong demand from large pharma

Quintiles CEO Tom Pike told investors last week that the company is seeing “very strong demand from...

Almac announces Government backed recruitment drive

Almac announces Government backed recruitment drive

Northern Ireland-based contractor Almac will create 348 jobs over the next five years in its pharma and...

Key Industry Events

 

Access all events listing

Our events, Events from partners...